theorysuit
2 weeks ago
1.81 to 4.92 with a normal retrace of 2.92. This stock still trades at under cash value. I have near to mid term fib targets of 6, 6.49, 6.87, 7.21, 7.58, 7.95, and 8.47 if you are looking for some exit points.
Monksdream
1 month ago
Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene editΒing toolbox, therΒaΒpeuΒtic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA. The listed name for MGX is Metagenomi, Inc. Common Stock